申请人:ST PHARM CO., LTD.
公开号:US10179785B2
公开(公告)日:2019-01-15
The present invention relates to a novel imidazotriazinone or imidazopyrazinone derivative, a tautomer thereof, a stereoisomer thereof and their mixture, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating a tankyrase-related disease, which contains the same as an active ingredient.
本发明涉及一种新型咪唑三嗪酮或咪唑吡嗪酮衍生物、其同分异构体、其立体异构体及其混合物,或其药学上可接受的盐;以及一种用于预防或治疗与毒蕈碱相关疾病的药物组合物,其中含有相同的活性成分。